GlassScriptPhysician profile
Erika M Schneider
NPI 1518162437
$669.86
in general payments reported to CMS, 2019-2025
15 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2022: $78.13 · 2023: $216 · 2024: $53.70 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.00 | 2019-2023 | Ubrelvy, Liletta |
| Coopersurgical, INC. | $98.58 | 2019-2024 | Mara Console, Summit Doppler |
| Mayne Pharma Commercial LLC | $78.02 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.95 | 2023-2025 | |
| Exeltis, USA INC. | $68.06 | 2019-2023 | Slynd |
| Baxter Healthcare | $51.43 | 2025 | Perclot |
| Avion Pharmaceuticals | $27.94 | 2019 | |
| Pfizer INC. | $26.75 | 2019-2022 | |
| Astellas Pharma US INC | $19.55 | 2025 | Veozah |
| Octapharma USA, INC. | $19.41 | 2025 | Fibryga |
| Exact Sciences Corporation | $19.12 | 2025 | The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $18.33 | 2025 | Gemtesa |
| Smith+Nephew, INC. | $16.17 | 2022 | |
| Hologic Sales and Service, LLC | $15.32 | 2023 | Aptima |
| Therapeuticsmd, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.